How insulin sensitivity affects metformin's ability to reduce age-related inflammation
The impact of insulin sensitivity on the potential of metformin to delay age-related inflammation
This study is looking at how well metformin, a common diabetes medication, can help healthy people delay inflammation as they age, especially for those who are more sensitive to insulin, so we can find out who might benefit from it before any health issues arise.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11078849 on NIH RePORTER |
What this research studies
This research investigates how insulin sensitivity influences the effectiveness of metformin in delaying age-related inflammation, which can impact overall health as we age. By analyzing samples from a previous trial, the study aims to identify characteristics of healthy individuals who might benefit from metformin before they develop age-related health issues. The research will focus on understanding the relationship between metabolic health and inflammation, particularly looking at cytokine profiles that may indicate inflammation levels. This could help in determining the best candidates for metformin treatment to enhance healthspan.
Who could benefit from this research
Good fit: Ideal candidates for this research are healthy adults who are insulin resistant or at risk of developing age-related health issues.
Not a fit: Patients who are already experiencing significant age-related health problems or chronic inflammatory diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help identify individuals who would benefit from metformin to prevent age-related inflammation and improve their overall health as they age.
How similar studies have performed: Previous research has shown promising results in using metformin for metabolic health improvements, suggesting potential for success in this novel approach.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Nikolajczyk, Barbara — University of Kentucky
- Study coordinator: Nikolajczyk, Barbara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.